|
|
|
|
Science Sparks @ ACTREC
|
 3rd August 2026 |
Vol. No. 15 ; Issue No.746 |
|
|
Publications
|
|
1. Agrawal A, Choudhury S, Mv Manikandan, Ghosh S, Dev I (2026). Head and Neck Cancers. PET Clinics
2. Sinha S, Kumar A, Mohanty S, Budrukkar A, Swain M, Joshi A, Dhanawat A, Nair S, Joshi P, Singh A, Shetty R, Joy I, Ali R, Virkar A, Chaturvedi P, Prabhash K, Laskar SG (2026). Interobserver agreement in acute toxicity assessment during head and neck radiotherapy/chemoradiotherapy: Implications for endpoint selection in clinical trials. International Journal of Radiation Oncology, Biology, Physics.
3. Murthy V, Gulati S, Ghosh S, Sable S, Phurailatpam R, Patil D, Mhatre R, Chougle N, Solanki M, Singh M, Verma P, Singh P, Maitre P (2026). EMPTY-RT: A Phase 2 trial of prostate stereotactic body radiotherapy with an empty badder approach. International Journal of Radiation Oncology, Biology, Physics.
4. Chaturvedi A, Raj S, Patil J, Khanka T, Anilkumar A, Ghogale SG, Deshpande N, Girase K, Poojari S, Balaji K, Sengar M, Bagal B, Jain H, Punatar S, Gokarn A, Khattry N, Shetty D, Rajpal S, Gudapati P, Patkar N, Chatterjee G, Epari S, Shet T, Subramanian PG, Gujral S, Tembhare PR (2026). Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment. Cytometry Part B: Clinical Cytometry.
|
|
|
|
|
|
|
Video of the Week
|
|
| Spotlight on Breakthroughs in Bladder Cancer Care |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1943, The first electron linear accelerator for radiation therapy was developed.
|
|
|
|
Cancer News
|
| |
|
Blood cancer’s genetic warning signs may appear years early.
|
|
ScienceDaily, 31/07/2026
|
|
Blood cancers that eventually worsen may carry detectable genetic warning signs years before patients develop serious symptoms. The findings could lead to earlier intervention while also helping doctors distinguish true cancer from harmless age-related blood changes...
|
| |
|
|
|
|
| |
|
|
|
Iron-ing out ferroptosis-mediated T cell dysfunction in cancer.
|
|
Nature, 28/07/2026
|
|
T cell dysfunction restrains the efficacy of immune checkpoint blockade and CAR-T cell-based cancer therapies. Iron-mediated ferroptosis is now shown to contribute to the dysfunction of endogenous T cells and CAR-T cells, suggesting that inhibition of ferroptosis...
|
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
